Human herpesvirus 6-associated retrobulbar optic neuritis in an HIV-infected patient: Response to anti-herpesvirus therapy and long-term outcome

Journal of Medical Virology

Volumn 79, Issue 7, 2007, Pages 931-934

  Méchaï, Frédéric ^a   Boutolleau, David ^a   Manceron, Véronique ^a   Gasnault, Jacques ^a   Quertainmont, Yann ^a   Brosseau, Jean Paul ^a   Delfraissy, Jean François ^a   Labetoulle, Marc ^a   Goujard, Cécile ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

HHV 6; HIV; Optic neuritis

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; DARUNAVIR; ENFUVIRTIDE; FOSCARNET; GANCICLOVIR; LAMIVUDINE; RITONAVIR; VALGANCICLOVIR; VIRUS RNA;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONVALESCENCE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EYE EXAMINATION; FEMALE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; METABOLIC DISORDER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; RETROBULBAR OPTIC NEUROPATHY; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS LOAD; VIRUS REACTIVATION; VISUAL IMPAIRMENT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CEREBROSPINAL FLUID; FEMALE; HERPESVIRUS 6, HUMAN; HIV-1; HUMANS; MIDDLE AGED; OPTIC NEURITIS; ROSEOLOVIRUS INFECTIONS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34249885363     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20833     Document Type: Article

References (20)

1. Ahlqvist J, Fotheringham J, Akhyani N, Yao K, Fogdell-Hanhn A, Jaconson S. 2005. Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J Neurovirol 11:384-394.
2. Astriti M, Zeller V, Boutolleau D, Gautheret-Dejean A, Allen G, Seilhean D, Agut H, Bricaire F, Katlama C, Bossi P. 2005. Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir. J Infect 20:1-6.
3. Bethge W, Beck R, Jahn G, Mundinger P, Kanz L, Einsele H. 1999. Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation. Bone Marrow Transplant 24:1245-1248.
4. Birnbaum T, Padovan CS, Sporer B, Rupprecht TA, Ausserer H, Jaeger G, Pfister HW. 2005. Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompotent women treated with ganciclovir. Clin Infect Dis 40:887-889.
5. Boutolleau D, Fernandez C, Andre E, Imbert-Marcille BM, Milpied N, Agut H, Gautheret-Dejean A. 2003. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187:179-186.
6. Boutolleau D, Duros C, Bonnafous P, Caiola D, Karras A, De Castro N, Ouachée M, Narcy P, Gueudin M, Agut H, Gautheret-Dejean A. 2006. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 30:257-263.
7. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC. 1995. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc natl Acad Sci USA 92:7440-7444.
8. Cobo J, Ruiz MF, Figueroa MS, Antela A, Quereda C, Peroz-Elias MJ. 1996. Retinal toxicity associated with didanosine in HIV-infected adults. AIDS 10:1297-1300.
9. Cuomo L, Trivedi P, Cardillo MR, Gagliardi FM, Vecchione A, Caruso R, Calogero A, Frati L, Faggioni A, Ragona G. 2001. Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 63:45-51.
10. De Bolle L, Naesens L, De Clercq E. 2005. Update on Human Herpesvirus 6. Biology, clinical features and therapy. Clin Microbiol Rev 18:217-245.
11. De Clercq E, Niesens L, De Bolle L, Schols D, Zhang Y, Neyts J. 2001. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 11:381-395.
12. Dewhurst S. 2004. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 11 (suppl 2):105-111.
13. Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, Fillet AM, Mangenay N, Vidaud M, Dhedin N, Vernant JP, Agut H. 2002. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 100:27-35.
14. Isaacson E, Glaser CA, Forghani B, Amad Z, Wallace M, Armstrong RW, Exner MM, Schmid S. 2005. Evidence of human herpesvirus 6 infection in four immunocompetent patients with encephalitis. Clin Infect Dis 40:890-893.
15. Jabs DA. 1995. Ocular manifestations of HIV infection. Trans Am Ophtalmol Soc 93:623-683.
16. Knox KK, Carrigan DR. 1994. Disseminated active HHV-6 infections in patients with AIDS. Lancet 343:577-578.
17. Knox KK, Brewer JH, Henry JM, Harrington DJ, Carrigan DR. 2000. Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease. Clin Infect Dis 31:894-903.
18. Salahuddin SZ, Ablashi DV, Markham PD, Joseph SF, Sturzenegger S, Kaplan M. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601.
19. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1:1065-1067.
20. Yoshikawa T, Yoshida J, Hamaguchi M, Kubota T, Akimoto S, Ihira M, Nishiyama Y, Asano Y. 2003. Human herpesvirus 7-associated meningitis and optic neuritis in a patient after allogeneic stem cell transplantation. J Med Virol 70:440-443.